SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $558,619,991 | +10.8% | 4,608,315 | +4.6% | 0.06% | +12.7% |
| Q2 2023 | $504,356,754 | -1.2% | 4,404,093 | +18.9% | 0.06% | -11.3% |
| Q1 2023 | $510,376,000 | +316653.9% | 3,702,944 | +197.8% | 0.06% | +195.2% |
| Q4 2022 | $161,127 | -99.8% | 1,243,447 | +72.5% | 0.02% | +90.9% |
| Q3 2022 | $79,700,000 | +3.9% | 721,013 | -29.6% | 0.01% | 0.0% |
| Q2 2022 | $76,741,000 | -9.9% | 1,023,748 | -6.1% | 0.01% | +10.0% |
| Q1 2022 | $85,202,000 | -9.8% | 1,090,666 | +4.0% | 0.01% | -9.1% |
| Q4 2021 | $94,429,000 | -32.5% | 1,048,623 | -30.7% | 0.01% | -35.3% |
| Q3 2021 | $139,959,000 | +37.8% | 1,513,403 | +15.9% | 0.02% | +41.7% |
| Q2 2021 | $101,555,000 | +80.8% | 1,306,342 | +73.3% | 0.01% | +71.4% |
| Q1 2021 | $56,166,000 | -56.3% | 753,598 | -0.1% | 0.01% | -63.2% |
| Q4 2020 | $128,651,000 | -19.2% | 754,599 | -33.0% | 0.02% | -29.6% |
| Q3 2020 | $159,153,000 | -37.1% | 1,126,509 | -28.6% | 0.03% | -44.9% |
| Q2 2020 | $253,003,000 | +126.0% | 1,577,913 | +37.9% | 0.05% | +88.5% |
| Q1 2020 | $111,951,000 | -7.4% | 1,144,463 | +22.1% | 0.03% | +13.0% |
| Q4 2019 | $120,958,000 | +1451.7% | 937,350 | +806.0% | 0.02% | +1050.0% |
| Q3 2019 | $7,795,000 | -38.6% | 103,465 | +5.7% | 0.00% | 0.0% |
| Q2 2019 | $12,699,000 | -50.3% | 97,860 | -54.4% | 0.00% | -60.0% |
| Q1 2019 | $25,561,000 | +14.1% | 214,446 | +4.5% | 0.01% | 0.0% |
| Q4 2018 | $22,404,000 | +61.4% | 205,300 | +138.9% | 0.01% | +66.7% |
| Q3 2018 | $13,878,000 | -47.8% | 85,923 | -57.2% | 0.00% | -40.0% |
| Q2 2018 | $26,564,000 | -49.4% | 200,961 | -71.7% | 0.01% | -54.5% |
| Q1 2018 | $52,535,000 | +116.9% | 709,070 | +62.9% | 0.01% | +120.0% |
| Q4 2017 | $24,217,000 | +61.6% | 435,229 | +37.0% | 0.01% | +66.7% |
| Q3 2017 | $14,984,000 | +61.2% | 317,800 | +15.2% | 0.00% | +50.0% |
| Q2 2017 | $9,298,000 | +94.5% | 275,825 | +70.8% | 0.00% | +100.0% |
| Q1 2017 | $4,781,000 | +174.5% | 161,525 | +154.4% | 0.00% | – |
| Q4 2016 | $1,742,000 | -58.6% | 63,500 | -7.3% | 0.00% | -100.0% |
| Q3 2016 | $4,207,000 | +38145.5% | 68,500 | +11917.5% | 0.00% | – |
| Q2 2016 | $11,000 | -88.5% | 570 | -88.4% | 0.00% | – |
| Q1 2016 | $96,000 | -45.5% | 4,934 | +8.5% | 0.00% | – |
| Q4 2015 | $176,000 | -78.0% | 4,549 | -73.2% | 0.00% | – |
| Q3 2013 | $801,000 | -18.8% | 16,973 | -34.5% | 0.00% | – |
| Q2 2013 | $986,000 | – | 25,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |